New Hope: A Safety Study of NNZ-2566 in Patients With Rett Syndrome

This study is not yet open for participant recruitment.

Sponsor:

Neuren Pharmaceuticals Limited

Collaborators:

Baylor College of Medicine

Texas Children's Hospital

International Rett Syndrome Foundation

More information regarding this can be found on the links below. Kindly click on the links to read further.

http://clinicaltrials.gov/ct2/show/NCT01703533?term=Rett+Syndrome&rank=4

http://newsstore.fairfax.com.au/apps/previewDocument.ac?sy=age&ss=AGE&docID=GCA01358630NEU&backTo%3Dhttp%3A%2F%2Fmarkets.theage.com.au%2Fapps%2Fqt%2Fquote.ac%3Fcode%3Dneu%26submit%3DSearch%26securityType%3D0%26section%3Dsummary%26sortBy%3D0%26descContains%3D0&f=pdf

Source: ClinicalTrials.gov